Company intelligence / Profile preview

IQS

Berkeley, California, United Statessearchiqs.com ↗

Ownership: Private
Development stage: Other

Overview

iQ Biosciences is a specialized contract research organization (CRO) providing bioservices for drug discovery and preclinical studies. Their offerings include in vitro assays, bioconjugation expertise, immune cell supply, safety testing services, and functional characterization using both in vitro and in vivo models. They serve pharmaceutical companies, biotech firms, academic institutions, and diagnostic developers by supporting early-stage R&D through comprehensive project management and scientific guidance.

Modalities: Small moleculesBiologicsCell-based therapies
Industry: Contract Research Organization

Partnerships

No major public partnerships disclosed; works broadly with pharma/biotech/academic clients on a project basis

Beyond the preview

Go deeper on IQS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IQS.

Explore the full profile